XML 28 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Noncontrolling Interest [Member]
Temporary Equity, Including Portion Attributable to Noncontrolling Interests [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Balance, temporary equity, including noncontrolling interest at Dec. 31, 2019   $ 0 $ 194,631            
Balance (in shares) at Dec. 31, 2019 [1]         84,331,573        
Balance at Dec. 31, 2019 $ (198,682)       $ 10 $ 33,691   $ (233,957) $ 1,574
Proceeds from exercise of options (in shares) [1]         759,293        
Proceeds from exercise of options 612       $ 0 612   0 0
Stock-based compensation expense 3,277       0 3,277   0 0
Net loss (16,969)       0 0   (16,969) 0
Net income attributable to and accretion of redeemable noncontrolling interest   27 27            
Net income attributable to and accretion of redeemable noncontrolling interest (27)       0 0   (27) 0
Foreign currency translation adjustment 217       $ 0 0   0 217
Balance, temporary equity, including noncontrolling interest at Dec. 31, 2020   3,061 213,014            
Balance (in shares) at Dec. 31, 2020 [1]         100,068,469        
Balance at Dec. 31, 2020 $ (192,827)       $ 12 105,159 $ 0 (299,789) 1,791
Proceeds from exercise of options (in shares) 5,141,331       5,141,331 [1]        
Proceeds from exercise of options $ 8,242       $ 0 8,242 0 0 0
Common Stock issued upon vesting of restricted stock units (in shares) [1]         170,852        
Stock-based compensation expense 46,475       $ 0 46,475 0 0 0
Reclassification of earn-out RSUs to earn-out shares (714)       0 (714) 0 0 0
Repurchase of Common Stock (1,739)       0 0 (1,739) 0 0
Net loss (33,245)       0 0 0 (33,245) 0
Net income attributable to and accretion of redeemable noncontrolling interest (1,974) (1,974) (1,974)   0 0 0 (1,974) 0
Foreign currency translation adjustment   (63) (63)            
Foreign currency translation adjustment 526       $ 0 0 $ 0 0 526
Balance, temporary equity, including noncontrolling interest at Dec. 31, 2021 5,210 5,210 5,210            
Balance (in shares) at Dec. 31, 2021       181,821,767 [2] 181,821,767 [1]   143,564    
Balance at Dec. 31, 2021 250,355       $ 18 [2] 625,056 $ (1,739) (375,297) 2,317
Proceeds from exercise of options (in shares)       713,810 [2]     0    
Proceeds from exercise of options 1,036       0 [2] 1,036 $ 0 0 0
Common Stock issued upon vesting of restricted stock units (in shares)       92,430 [2]     0    
Common Stock issued upon vesting of restricted stock units 0       0 [2] 0 $ 0 0 0
Stock-based compensation expense 8,274       0 [2] 8,274 0 0 0
Reclassification of earn-out RSUs to earn-out shares (296)       0 [2] (296) 0 0 0
Repurchase of Common Stock (in shares) [2]       (135,000)          
Repurchase of Common Stock (743)       0 [2] 0 $ (743) 0 0
Repurchase of Common Stock (in shares)             135,000    
Net loss (11,053)       0 [2] 0 $ 0 (11,053) 0
Net income attributable to and accretion of redeemable noncontrolling interest   617 617            
Net income attributable to and accretion of redeemable noncontrolling interest (617)       0 [2] 0 0 (617) 0
Foreign currency translation adjustment   (9) (9)            
Foreign currency translation adjustment (1,719)       0 0 $ 0 0 (1,719)
Balance, temporary equity, including noncontrolling interest at Mar. 31, 2022   5,818 5,818            
Balance (in shares) at Mar. 31, 2022       182,493,007 [2]     278,564    
Balance at Mar. 31, 2022 245,237       $ 18 [2] 634,070 $ (2,482) (386,967) 598
Balance, temporary equity, including noncontrolling interest at Dec. 31, 2021 5,210 5,210 5,210            
Balance (in shares) at Dec. 31, 2021       181,821,767 [2] 181,821,767 [1]   143,564    
Balance at Dec. 31, 2021 $ 250,355       $ 18 [2] 625,056 $ (1,739) (375,297) 2,317
Proceeds from exercise of options (in shares) 1,799,665     1,799,665 [2]     0    
Proceeds from exercise of options $ 2,818       0 [2] 2,818 $ 0 0 0
Common Stock issued upon vesting of restricted stock units (in shares)       1,784,993 [2]     0    
Common Stock issued upon vesting of restricted stock units 0       0 [2] 0 $ 0 0 0
Stock-based compensation expense 37,210       0 [2] 37,210 0 0 0
Reclassification of earn-out RSUs to earn-out shares (885)       0 [2] (885) 0 0 0
Repurchase of Common Stock (in shares) [2]       (4,046,186)          
Repurchase of Common Stock (19,927)       0 [2] 0 $ (19,927) 0 0
Repurchase of Common Stock (in shares)             4,046,186    
Net loss (38,688)       0 [2] 0 $ 0 (38,688) 0
Net income attributable to and accretion of redeemable noncontrolling interest   2,942 2,942            
Net income attributable to and accretion of redeemable noncontrolling interest (2,942)       0 [2] 0 0 (2,942) 0
Foreign currency translation adjustment   61 61            
Foreign currency translation adjustment (311)       0 0 $ 0 0 (311)
Balance, temporary equity, including noncontrolling interest at Dec. 31, 2022 14,007 14,007 14,007            
Balance (in shares) at Dec. 31, 2022       185,277,588 [2]     4,189,750    
Balance at Dec. 31, 2022 $ 229,147       19 [2] 665,715 $ (21,666) (416,927) 2,006
Proceeds from exercise of options (in shares) 680,385     680,385 [2]     0    
Proceeds from exercise of options $ 1,131       0 [2] 1,131 $ 0 0 0
Common Stock issued upon vesting of restricted stock units (in shares)       1,254,710 [2]     0    
Common Stock issued upon vesting of restricted stock units 0       0 [2] 0 $ 0 0 0
Stock-based compensation expense 8,104       0 [2] 8,104 0 0 0
Reclassification of earn-out RSUs to earn-out shares (182)       0 [2] (182) 0 0 0
Repurchase of Common Stock (in shares) [2]       (424,876)          
Repurchase of Common Stock (1,811)       0 [2] 0 $ (1,811) 0 0
Repurchase of Common Stock (in shares)             424,876    
Net loss (9,182)       0 [2] 0   (9,182) 0
Net income attributable to and accretion of redeemable noncontrolling interest   15 15            
Net income attributable to and accretion of redeemable noncontrolling interest (15)       0 [2] 0 $ 0 (15) 0
Foreign currency translation adjustment   35 35            
Foreign currency translation adjustment 49       0 0 $ 0 0 49
Balance, temporary equity, including noncontrolling interest at Mar. 31, 2023 14,057 $ 14,057 $ 14,057            
Balance (in shares) at Mar. 31, 2023       186,787,807 [2]     4,614,626    
Balance at Mar. 31, 2023 $ 227,241       $ 19 [2] $ 674,768 $ (23,477) $ (426,124) $ 2,055
[1] As part of the Business Combination (as disclosed in "Note 3 — Business Combination"), all per share information has been retroactively adjusted using an exchange ratio of 8.69144 per share.
[2] As part of the Business Combination (as disclosed in “Note 3 — Business Combination”), all per share information has been retroactively adjusted using an exchange ratio of 8.69144 per share.